Upregulation of CCL2 via ATF3/c-Jun interaction mediated the Bortezomib-induced peripheral neuropathy.

Cuicui Liu,Shuo Luan,Handong OuYang,Zhenzhen Huang,Shaoling Wu,Chao Ma,Jiayou Wei,Wenjun Xin
DOI: https://doi.org/10.1016/j.bbi.2015.11.004
2016-01-01
Abstract:•Painful peripheral neuropathy induced by chemotherapy drugs often serves as the common reason for treatment discontinuation or dose reduction rather than tumor progression, the underlying mechanism in the Bortezomib-induced painful peripheral neuropathy remains unclear.•Here we found that upregulated CCL2 expression in DRGs was critical to the development of BTZ-induced mechanical allodynia.•Furthermore, c-Jun might be essential for BTZ-induced CCL2 upregulation via binding directly to the specific position of the ccl2 promoter.•Finally, c-Jun and ATF3 interaction might contribute to the enhanced transcription of ccl2 after BTZ treatment.•Our findings revealed a novel mechanism underlying Bortezomib-induced painful peripheral neuropathy.
What problem does this paper attempt to address?